🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalMedical tourism for GLP-1 — Mexico, Turkey, India pricing

Medical tourism for GLP-1 — Mexico, Turkey, India pricing

AussieAnna Sat, Feb 14, 2026 at 11:22 AM 4 replies 426 viewsPage 1 of 1
AussieAnna
Member
678
2,890
Jun 2024
Sydney, AU
Feb 14, 2026 at 12:47 PM#1

Can someone give me a current state of affairs on compounded tirzepatide as of Q1 2026? It feels like the landscape changes every week.

Last I heard, FDA removed tirzepatide from the shortage list in late 2024 and has been going after compounders. But I'm still seeing some pharmacies advertising it. What's the actual legal status? And what are people paying?

30 18TrialNerd_Beth, HPLC_Greg, LibrarianMeg and 27 others
Reply Quote Save Share Report
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
Feb 14, 2026 at 1:04 PM#2

Here's the current status as of March 2026:

Legal status: Complicated. FDA removed tirzepatide from the shortage list in October 2024 and has been issuing warning letters and cease-and-desist orders to compounders. HOWEVER, multiple lawsuits are challenging these enforcement actions, and some pharmacies have obtained temporary restraining orders allowing them to continue compounding.

Availability: Reduced but not eliminated. Several 503B facilities stopped voluntarily. Others are still compounding under legal protection from court orders. Some 503A pharmacies argue they're exempt from the enforcement because they compound on a patient-specific basis.

Pricing (where available):

  • Compounded tirzepatide 10mg vial: $150-275/month
  • Compounded tirzepatide 30mg vial: $300-450 (multi-month supply at lower doses)

Compare to brand Mounjaro/Zepbound at $1,050-1,200/month without insurance.

Last edited: Feb 14, 2026 at 3:04 PM
23 21Dr.RaviCardio, jennifer_SEA, tyler_CSCS and 20 others
Reply Quote Save Share Report
DerekSJ_a1c
Member
378
1,678
Aug 2024
San Jose, CA
Feb 14, 2026 at 1:21 PM#3

The key legal case right now is the litigation in the 5th Circuit involving the Outsourcing Facilities Association. The core argument is whether compounded tirzepatide using a different salt form constitutes an "essentially a copy" of branded Mounjaro/Zepbound. If the courts rule it's NOT a copy, compounding could resume broadly.

There's also a constitutional argument about FDA overreach in enforcement. Some pharmacies argue that FDA's administrative determination that the shortage ended is arbitrary and capricious because patients still can't access the medication due to cost.

It's a legal mess. But the practical takeaway: compounded tirzepatide is still available from some pharmacies, just fewer than before.

1 2rachel_ABQ
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
labquiet_amy
Senior Member
1,234
6,789
Mar 2024
Cambridge, MA
Feb 14, 2026 at 1:38 PM#4

So if I find a pharmacy still compounding it, am I taking any legal risk as a patient? Can FDA come after me for buying it?

27 21bri_stats, pete_manc_UK, anna.melb_AU and 24 others
Reply Quote Save Share Report
GenomicsKate
Member
345
1,890
Oct 2024
Cambridge, MA
Feb 14, 2026 at 1:55 PM#5

No. FDA enforcement actions target pharmacies and prescribers, not patients. You are not breaking any law by filling a valid prescription for a compounded medication. The legal risk sits entirely with the pharmacy and potentially the prescriber.

That said, availability risk is real. If your pharmacy gets shut down mid-treatment, you're back to square one (see the "pharmacy shut down" thread).

44 20claudia_zurich, nancy_portland, rick_sfbay and 41 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register